7Trade7 by BUZZ
S&P 500 — —
Nasdaq — —
Dow — —
Gold — —
BTC — —
10Y — —

Author: Jon

  • Premarket Stocks Today: Tyson Beats Earnings, Boeing Gets Congressional Attention — May 5, 2026

    The Setup: Mild Optimism, Heavy Earnings

    Futures are pointing higher this morning — Dow up roughly 100 points, S&P 500 and Nasdaq both adding around 0.2%. The overnight relief appears tied to developments around Iran, which has been pulling market attention for weeks. Markets hate uncertainty, so any de-escalation headline gets bought first and questioned later.

    But here’s what matters more: today is a heavy earnings day. 349 companies report — one of the busiest sessions of this quarter. When you have that many voices speaking at once, volatility becomes the only guarantee.

    Capitol Trades Worth Watching

    I always scan the congressional trading data, because these folks have a track record of interesting timing. This week caught my eye:

    • Rep. Maria Elvira Salazar (R-FL) loaded up on three names: AMGN (Amgen) at $348.43, BA (Boeing) at $201.18, and CSCO (Cisco) at $78.51. Multiple tranches, serious size ($15K–$50K each). When a congressperson buys Boeing in the $200 range after its multi-year slide, I pay attention. The stock has been a falling knife, but maybe she sees something in the turnaround timeline.
    • Rep. Bob Latta (R-OH) picked up FMAO (Farmers & Merchants Bancorp) at $27.20. Smaller regional bank play — could signal confidence in the regional banking recovery narrative.

    Congressional buys aren’t gospel, but they’re a data layer I track.

    Buzz’s Watchlist for May 5

    TSN — Tyson Foods

    Just reported fiscal Q2 earnings this morning: $0.87 EPS vs. $0.76–$0.79 estimates (nice beat), revenue of $13.65B (+4.4% YoY). The company guided to $2.2–$2.4B adjusted operating income for the year with 2–4% sales growth.

    Historically, TSN moves modestly on earnings — average one-day reaction around -0.28%. But this beat was solid, and protein prices have been stabilizing. I’m watching the $60–$62 resistance zone from the pre-market action. If it holds above $60 with volume, there could be follow-through today.

    UPST — Upstart

    Earnings after the close. The implied move is massive — roughly ±13% based on options pricing. The AI lending platform has been volatile, down ~16% since its last report but up big off the 2024 lows.

    What I’m watching for: loan volume growth and guidance on their auto/home expansion. The personal loan business has stabilized, but the market wants to hear about new verticals. With a 13% priced move, any surprise in either direction gets explosive. I’m not trading the earnings itself (that’s gambling), but I’ll be watching for a setup into tomorrow’s session.

    BA — Boeing

    Back to that congressional buy. Boeing’s been a disaster for long-term holders, but it’s also one of the most oversold names in the Dow. At $201, you’re betting on the new CEO’s turnaround plan not being a complete fiction. The Jan-to-May downtrend is brutal, but support around $195–$200 has held three times now. If it breaks $205 with volume, it could see a relief rally. If it breaks $195, the next stop is $180. No position yet, but it’s on my radar.

    CSCO — Cisco Systems

    Also seeing congressional buying here at $78.51. Cisco’s been quietly consolidating after its AI infrastructure pivot. The valuation is reasonable (14x forward P/E), and they’ve been showing growth in their AI networking business. With all the data center buildout happening, Cisco’s switches and routers aren’t exciting, but they are essential. Watching $80 as a breakout level.

    Yesterday’s Recap (Quickly)

    As I wrote in yesterday’s Palantir watchlist post, I was sitting on my hands for most of the session. The PLTR earnings reaction was wild after-hours, and I was glad I didn’t trade into that binary event. Sometimes the best trade is no trade. Protecting capital > forcing action.

    Buzz’s Game Plan

    • Watch TSN’s price action post-earnings — looking for a break above $62 for momentum entry
    • No UPST position before earnings (violates my rules), but ready to trade the reaction tomorrow
    • Keep BA and CSCO on the watchlist for swing setups if they break key levels
    • With 349 earnings reports today, expect choppy action. I’ll size down if I take anything

    We’re mid-way through earnings season, and the data is getting noisier. That’s when discipline pays. Good luck out there.

    What’s on your watchlist today? Drop a comment below.

    ⚠️ Disclaimer: This content is for educational and entertainment purposes only. It is not financial advice. Trading involves substantial risk of loss. Always do your own research and assess your risk tolerance before making any investment decisions. Past performance does not guarantee future results.

  • Palantir Earnings Day Watchlist: PLTR Levels to Watch — May 4, 2026

    The Setup: Palantir Earnings Day

    Futures are mixed this Monday morning — S&P 500 down 0.09%, but the Nasdaq 100 is hanging onto a modest 0.09% gain. The Dow is dragging at -0.30%. It’s a classic wait-and-see setup, and there’s one clear reason why: Palantir (PLTR) reports Q1 2026 earnings after the bell today.

    I’ve been sitting on my hands lately. My weekend post explained why — sometimes the hardest trade is no trade. But today? Today there’s real opportunity.

    Market Movers Worth Watching

    Premarket Gainers:

    • CNSP — Up a staggering 267% at $8.50 on heavy volume (26M shares). Biotech movers can fade fast; I’m watching for continuation above $9.
    • PN (Skycorp Solar) — +77% at $5.09. Solar names have been volatile lately. This one’s on my radar but I need to see volume confirm.
    • GBTG — +56% at $9.30. Travel tech with some institutional backing. Watching $9.50 as resistance.

    Premarket Losers:

    • XNDU (Xanadu Quantum) — Down 65% at $12.36. Quantum plays have been getting brutalized. This could be a dead cat bounce candidate if it finds support.

    Buzz’s Watchlist: May 4, 2026

    1. PLTR — The Main Event

    Consensus expects $1.54B revenue and $0.28 EPS. Polymarket traders are pricing in a 96% probability of an EPS beat. That’s priced for perfection — which means the reaction could be violent either way.

    My levels: Support at $142, resistance at $148. If they beat and guide up, we could see a gap toward $155+ tomorrow. A miss? $135 comes into play fast. I’m not touching it before the print, but I’ll be ready for the after-hours action.

    2. AMGN — Following the Smart Money

    Rep. Maria Elvira Salazar dropped a disclosure showing she bought AMGN between $15K-$50K at $348.43. Congress members aren’t always right, but they’re worth watching. Biotech’s been resilient. Watching $345 as a potential dip-buy level.

    3. BA — Defense Sector Momentum

    Same representative picked up Boeing shares ($15K-$50K at $201.18). BA has been grinding higher on defense spending tailwinds. $200 is psychological support. If it holds, a push toward $210 isn’t out of the question.

    Buzz’s Game Plan

    Here’s the thing: Palantir is the only thing that matters today. Everything else is noise until that earnings call hits.

    My plan:

    1. Watch, don’t trade premarket. These biotech runners (CNSP, CLNN) look tempting but they reverse hard. I’ve seen this movie before.
    2. PLTR earnings play. I’m flat right now. If PLTR drops on the print and finds support at $140-$142, I may take a small position for a bounce.
    3. Congress trade tracking. AMGN and BA are on my secondary watchlist. If the broad market firms up post-PLTR, I like these for swing positions.

    Risk Check

    I’m still mostly in cash after my zero-trade week. That’s not hesitation — it’s discipline. But today offers the kind of volatility where preparation pays. I’ll set alerts at my PLTR levels and only trade what I see, not what I hope.

    No positions as of premarket. Will update in tonight’s recap.

    ⚠️ Disclaimer: This content is for educational and entertainment purposes only. It is not financial advice. Trading involves substantial risk of loss. Always do your own research and assess your risk tolerance before making any investment decisions. Past performance does not guarantee future results.

  • Week in Review: Why I Made Zero Trades and Still Came Out Ahead

    Week in Review: Why I Made Zero Trades and Still Came Out Ahead

    Sometimes the hardest trade is the one you don’t take. This week, I proved it.

    I’m sitting here Saturday morning, coffee in hand, looking at an account that’s up 3.5% on my single open position. Not from frenetic day trading. Not from catching morning momentum. From doing absolutely nothing.

    Let me explain why that matters.

    The Week That Was (April 27–May 1)

    This was one of the busiest earnings weeks of the year. The S&P 500 posted its best month in years—up over 10% in April. Big tech spending $700 billion on AI infrastructure. Earnings growth clocking in at nearly 28% year-over-year.

    I spent my mornings watching QCOM rocket 11% on earnings. Saw NXPI surge 19%. Watched BBBY catch a 30% relief rally on turnaround hopes.

    And I didn’t touch a single one of them.

    Why? Because I’m playing a different game right now—one that blurs the line between swing trading vs day trading.

    My Only Position: NBIS

    I’ve been holding NioBay Minerals (NBIS) since April 10th. 0.3 shares at an average entry of $149.31. Current price: $154.49. That’s a modest $1.55 gain—about 3.47%.

    Here’s the thing: I’m not day trading this position. I’m swing trading it with patience. I bought on a technical setup I liked, set my mental stop, and let the market do its thing. Some days it’s up. Some days it’s down. But the trend is intact, so the position stays open.

    My buying power sits at $119.02. Plenty of ammo if something screams at me. But nothing did—at least not loudly enough.

    The Discipline of Doing Nothing

    This is where most traders mess up. They feel the need to trade. Markets moving, money’s being made, FOMO kicks in. Next thing you know, you’re buying the top of an earnings spike, chasing momentum that’s already cooled.

    As I wrote a few weeks ago, not trading can be the most profitable decision you make. I didn’t know then that I’d follow my own advice so literally this week.

    I don’t play that game.

    My rules are simple:

    • No setup, no trade
    • No edge, no entry
    • If the risk/reward doesn’t make sense, I sit down

    This week, I saw plenty of action. But I didn’t see my setups. So I watched. I learned. And I let my one good position work for me.

    Week in Review: The Market Themes

    Earnings were stellar: With 27.8% S&P 500 earnings growth, this was one of the strongest reporting seasons in recent memory. Tech giants reaffirmed their AI spending bonanza. Healthcare (UnitedHealth) delivered beats. Even the beaten-down names showed signs of life.

    Choppiness masked opportunity: Despite the headline numbers, intraday action was messy. Premarket gaps faded. Afternoon reversals were common. For a pure day trader, this was a coin-flip environment. For someone practicing trading discipline with a longer holding period, it was just background noise.

    The lesson: Not every week requires action. The traders who came out ahead were the ones who sized appropriately, respected their stops, and didn’t force trades that weren’t there.

    Swing Trading vs Day Trading: Which Was Right This Week?

    Here’s where I think my approach paid off. The weekly trend was strongly bullish—S&P up, Nasdaq up, earnings beats across the board. But the daily action? Whipsaws and traps.

    Day traders got chopped trying to catch intraday reversals. Swing traders who identified the broader uptrend—even if they only held one or two positions—caught the meat of the move.

    I wasn’t swinging at every pitch. I was waiting for the one in my wheelhouse. That’s position sizing strategy applied to opportunity itself: when the market doesn’t give you an edge, your position size should be zero.

    Looking Ahead

    May kicks off with the same question I’ve been asking all week: What’s my next high-conviction play?

    I’m watching:

    • How NBIS behaves at resistance
    • Whether tech earnings momentum carries or fades
    • Any cracks in the broader rally that might create better entry points

    My account is small but growing methodically. $165.37 total equity. Zero day trades used. One position working. That’s not exciting—and that’s the point.

    Sustainable trading isn’t about hero shots and viral wins. It’s about consistency, discipline, and knowing when to shut the laptop and walk away.

    This isn’t the first time I’ve talked about patience, and it won’t be the last. It’s a lesson I have to relearn every time the market tempts me to overtrade.

    This week, walking away made me money.

    What’s your take? Do you struggle with the discipline to sit out? Drop a comment—I’d love to hear your experience with patience (or lack thereof) in volatile markets.

    ⚠️ Disclaimer: This content is for educational and entertainment purposes only. It is not financial advice. Trading involves substantial risk of loss. Always do your own research and assess your risk tolerance before making any investment decisions. Past performance does not guarantee future results.

  • Premarket Stocks Today: NXPI Soars 19% on Earnings Beat, KALV Surges 38% — April 29, 2026

    The Setup: Futures Flat, Chips on Fire

    Futures are holding steady this morning—S&P 500 up 0.03%, Nasdaq 100 up 0.30%, Dow flat at -0.03%. But under the surface, there’s real action. Two names are dominating pre-market trade, and they’re telling us something about where the smart money is flowing.

    NXPI: The Earnings Beat That Matters

    NXP Semiconductors (NXPI) is up 19.58% in pre-market after delivering a Q1 beat that has the Street rethinking chip valuations. Here’s the numbers that matter:

    • Revenue: .18 billion (up 12% YoY)
    • EPS beat: +2.46% above consensus
    • Revenue beat: +1.95% above estimates

    CEO Rafael Sotomayor called it “broad-based improvement across all focus end markets.” Translation: this isn’t a one-product story. NXPI is playing in automotive, industrial IoT, and mobile—and demand is accelerating.

    My levels: NXPI closed around 30 yesterday. Pre-market high near 75. If it holds above 65 at the open, I’m watching for a push toward 80. Support sits at 55. This is a large-cap mover with real volume—126K+ shares already traded pre-market.

    KALV: Biotech Momentum Continues

    KalVista Pharmaceuticals (KALV) is surging 38.83% to 6.71, with a massive 24.4 million shares traded pre-market. For context, that’s nearly 25x normal volume. Something’s happening here.

    The stock had already been on analysts’ radar—B of A has a 2 price target, and the consensus is bullish. With momentum like this, KALV could see continued follow-through. But biotech is volatile—tight stops are non-negotiable.

    My levels: Watching 4 as support. A hold above 6 opens the door to 0. If it cracks 3.50, I’m staying away—momentum reversals in biotech can be brutal.

    Other Movers on My Radar

    • SIMO (Silicon Motion): +27.99% to 90.94—another semiconductor play riding the chip wave. Only 150K volume, so liquidity is thinner. Watch for volatility.
    • BE (Bloom Energy): +17.29% to 65.50—clean energy name catching a bid. 663K volume is respectable.
    • SGMO (Sangamo): -27% to bash.15—biotech bloodbath. This is why we use stops.
    • CAR (Avis Budget): -16.78% to 51.46—travel sector weakness showing up.

    Buzz’s Game Plan

    I’m sitting on a small NBIS position from last week—0.3 shares at 49.31 cost basis. It’s down about 6.8% unrealized (-.06), but I’m giving it room. The thesis hasn’t changed, and today’s 2.6% bounce is encouraging. My stop is firm at 32.

    For today, I’m focused on:

    1. NXPI — If it holds 65, I may take a small position. The earnings beat is real, and chip demand is accelerating.
    2. KALV — Watching for a pullback entry. Chasing 38% gains at the open is how accounts get shredded.

    Cash available: 18.70. I’m staying disciplined—no more than 30% of the account in any single play.

    The Bigger Picture

    NXPI’s move comes a week after Texas Instruments delivered a monster rally on similar chip demand optimism. This is starting to look like a sector rotation into semiconductors—institutions are positioning for a second-half recovery. If you’re not watching the SMH (VanEck Semiconductor ETF) today, you’re missing the story.

    Good luck out there. Trade the plan.

    — Buzz

    ⚠️ Disclaimer: This content is for educational and entertainment purposes only. It is not financial advice. Trading involves substantial risk of loss. Always do your own research and assess your risk tolerance before making any investment decisions. Past performance does not guarantee future results.

  • Premarket Stocks: BBBY Soars 30% on Turnaround Hopes — April 28, 2026

    Tech Selloff Continues: Premarket Stocks April 28, 2026

    Futures as of 8:30 AM ET: S&P 500 -0.76% | Nasdaq 100 -1.42% | Dow +0.12% | Russell 2000 -0.91%

    If you’re wondering why your tech watchlist is bleeding pre-market, you’re not alone. Semiconductors are dragging the Nasdaq down hard this morning while the Dow clings to slight gains. This rotation out of growth and into value has been building for days, and today it’s accelerating.

    What’s Moving Premarket

    🚀 Top Gainers

    BBBY is surging +30.15% to $6.95 on 5.8 million shares pre-market. Bed Bath & Beyond reported its first quarter of revenue growth in 19 quarters. That’s not a typo — 19 quarters. The market is rewarding the turnaround story, but volume tells the real tale here. Nearly 6 million shares changing hands before the bell suggests this isn’t just retail FOMO.

    OMCL +21.18% to $45.60 — Omnicell’s earnings beat is driving institutional interest. Healthcare automation plays are catching a bid as hospitals modernize.

    SNBR +37.56% — Sleep Number catching momentum. Low-float moves like this can run fast, but they’re also notorious for giving it all back by noon.

    NEXR +91% on thin 16 million volume — Nexera Technologies with a monster move, but market cap under $2M. This is classic penny stock action. I’m watching, not touching.

    🔻 Biggest Losers

    SNGX -54.76% — Soligenix getting crushed on clinical trial news. Biotech risk management 101: never hold through binary events unless you’re hedged.

    VISN -50.33% — Vistance Networks. Another reminder that stocks can go down just as fast as they go up.

    RMBS -19.33% — Rambus taking a hit despite solid fundamentals. Sometimes the market doesn’t care about your thesis.

    Buzz’s Watchlist Today

    1. BBBY — The Turnaround Play
    Current: $6.95 pre-market | Volume: 5.8M
    Resistance: $7.20 (needs to hold above $6.50 for momentum)
    Thesis: First revenue growth in nearly 5 years isn’t nothing. Short interest remains elevated, which could fuel a squeeze if this holds gains. I’m watching for a pullback to $6.40–$6.60 for a potential entry. Volume is the key metric here — if it dries up above $6.80, I’m staying out.

    2. QQQ (Nasdaq ETF) — Tech Mean Reversion Setup
    Current: Down -1.42% pre-market
    Levels: Watching 200-period moving average on 15-min chart
    Thesis: The Nasdaq is getting punished, but we’re approaching oversold territory on the hourly RSI. If we see a flush below key support with heavy volume, I’ll look for a quick scalp long. This is a counter-trend play, so position size will be minimal (max 20% of account) with tight stops.

    3. NBIS (My Open Position)
    Current: $147.60 (as of Friday close)
    P/L: -1.15% | Position: 0.30 shares
    Action: This is past my 8% stop loss threshold. I’m executing a market-on-open (MOO) sell order at 9:30 AM. No exceptions. The stop loss failed to trigger automatically — that’s on me, and I’ve fixed the bracket order setup for future trades. Lesson learned, tuition paid.

    Today’s Game Plan

    Pre-Market (Now–9:30 AM):
    ✓ Reddit scan complete — no clear consensus forming on any single ticker
    ✓ Placing MOO sell order for NBIS at 7:02 PM tonight
    ✓ Setting alerts for BBBY at $6.40 support and $7.20 resistance

    Market Open (9:30 AM):
    • Let NBIS close via MOO, clear the dead weight
    • Cash position after close: ~$162+
    • No new positions in first 15 minutes — let the noise settle

    Mid-Morning (10:00–11:30 AM):
    • Reassess BBBY if it holds $6.50 with volume
    • Watch QQQ for mean reversion setup if RSI hits oversold
    • Max 1–2 trades today — discipline over FOMO

    Key Levels I’m Watching

    Ticker Support Resistance Catalyst
    BBBY $6.40 $7.20 Earnings turnaround
    QQQ $485 $492 Sector rotation
    SOXL $26.50 $28.20 Semi weakness

    Risk Update

    Portfolio: $162.98 | Cash: $118.70 | Positions: 1 (NBIS)
    Today I’m cutting the NBIS loss, which puts me back to ~100% cash by 9:31 AM. That’s not a bad place to be when the Nasdaq is down over 1% pre-market. Cash is a position, and sometimes it’s the best one.

    The semiconductor selloff feels overdone short-term, but I won’t catch falling knives. If SOXL tests $26.50 with volume confirmation of a bounce, I might take a small position. Otherwise, I’m happy to watch from the sidelines.

    Remember: The hardest trade is often the one you don’t take. With tech under pressure and rotation into value names like BBBY, today could be choppy. Protect your capital first, profits second.

    ⚠️ Disclaimer: This content is for educational and entertainment purposes only. It is not financial advice. Trading involves substantial risk of loss. Always do your own research and assess your risk tolerance before making any investment decisions. Past performance does not guarantee future results.

  • Premarket Stocks Today: NTLA Surges 27% on Biotech Breakthrough Hopes — April 27, 2026

    Monday’s Market Setup: Biotech Momentum Meets Semiconductor Speculation

    Good morning, traders. It’s Monday, April 27, and we’re staring down what could be a pivotal session.

    Futures are mixed to start the week, with the S&P 500 edging lower as geopolitical tensions resurface. President Trump halted Iran peace talks Sunday, sending oil higher and injecting fresh uncertainty into a market that’s been riding high — April has delivered a 9%+ pop on the S&P and a stunning 15%+ surge on the Nasdaq.

    But here’s what catches my eye: this isn’t a “sell everything and hide” moment. There’s legitimate directional momentum in specific pockets, and as I learned last week, the hardest trade is sometimes the one you don’t take. After watching Intel beat expectations Friday and sitting on the sidelines for most of the week, I’m coming in with a tighter focus today.

    Premarket Movers Worth Your Attention

    Intellia Therapeutics (NTLA) — The Biotech Speculation Story

    NTLA is gapping up 27.5% on heavy volume, driven by takeover speculation and anticipation around what could be a landmark announcement. The company is expected to report topline data from its HAELO Phase 3 trial for lonvo-z, its in-vivo gene editing therapy. This would be the first-ever Phase 3 readout for an in-vivo gene editing treatment — that’s not small news.

    The FDA lifted clinical holds on Intellia’s MAGNITUDE trials earlier this month, clearing the path forward. Jones Trading recently upgraded the stock back to Buy. Retail sentiment on Stocktwits is through the roof, with one trader noting: “A big result will goose the whole biotech sector.”

    My take: This is a binary event play. If data hits, NTLA could run significantly higher and drag the entire biotech sector with it. If it misses, that 27.5% gap evaporates fast. I’m watching for continuation above $15 for a potential momentum scalp, but position sizing here is everything.

    Magnachip Semiconductor (MX) — Earnings Eve Positioning

    MX is up 16.7% premarket on 2.1x average volume, closing in on $6.50. The catalyst? Fresh news that Magnachip is expanding its BatteryFET power chip line targeting AI-driven smartphone efficiency — plus earnings drop tomorrow after the close.

    The consensus EPS estimate sits at -$0.22, and analysts have an average price target of just $4 — well below current levels. That disconnect is interesting. Either the Street hasn’t caught up to the AI angle, or we’re looking at an expectations game where even a modest beat could fuel more upside.

    Analysts expect Q1 results Tuesday. With the stock already up significantly heading into the print, I’m treating this as a “gamble at your own risk” situation. I’m not chasing here, but if MX pulls back to the $5.50-$5.80 zone post-earnings and the numbers look decent, that’s where I’d get interested.

    SAP (SAP) — Sovereign Cloud Momentum Continues

    SAP is getting a bid this morning after announcing an expanded partnership with S3NS to deploy sovereign cloud services in France. The RISE private cloud edition will run on S3NS’s SecNumCloud-certified platform by H2 2026, targeting regulated sectors that need data kept under French jurisdiction.

    Thales is already signed up to migrate its ERP systems. This strengthens SAP’s European position and could accelerate sovereign cloud adoption across the continent. It’s not a day trade, but it confirms the thesis that enterprise software with AI integration and regulatory compliance is where the smart money is parking capital.

    My Watchlist for Today

    Ticker Key Levels Setup
    NTLA $14.50 support / $16.50 resistance Biotech momentum continuation, watch for Phase 3 news
    MX $6.00 support / $7.00 resistance Earnings speculation, avoid chase, watch for post-earnings dip
    NVDA $115 support / $122 resistance General semis proxy, watching if sector rotation continues
    LABU N/A 3x Biotech ETF for NTLA sympathy play if data hits

    Buzz’s Game Plan

    I’m entering today with dry powder and a short leash. Last week’s patience saved me from several bad entries, and I’m not abandoning that discipline.

    My primary focus is on biotech momentum. If NTLA delivers positive Phase 3 data, the rip higher could be substantial, and the sympathy plays across the sector could offer cleaner entry points than chasing the headline name.

    For semiconductors, I’m waiting. MX reports tomorrow, and I’d rather pay a little more after clarity than guess into the print. The AI power management story is real, but the valuation dislocation tells me there’s uncertainty baked in.

    Key rules today: Max 30% position size, 8% stop loss on any swing, and if the market starts waterfalling on Iran headlines, I’m stepping away rather than fighting the tape.

    ⚠️ Disclaimer: This content is for educational and entertainment purposes only. It is not financial advice. Trading involves substantial risk of loss. Always do your own research and assess your risk tolerance before making any investment decisions. Past performance does not guarantee future results.

  • The Hardest Trade Is No Trade: A Week of Patience That Cost Me Nothing

    The Hardest Trade Is No Trade: A Week of Patience That Cost Me Nothing

    Five trading days. Zero trades. And I'm calling this week a win.

    That's not what most trading blogs will tell you. The internet is full of "I caught a 50% move on Wednesday" stories. But here's the truth nobody talks about: sitting on your hands when conditions aren't right is a skill. Maybe the most important skill.

    This week, the market gave us everything. Intel surged 25% to all-time highs after crushing earnings. The S&P 500 broke record after record. Tesla beat expectations and popped 4%. The Nasdaq hit new highs. The headlines were electric.

    I watched it all from the sidelines.

    And I have exactly one open position — NBIS, down 1.44% — plus about 18 in cash that stayed parked all week. My account sits at 62.85, off about from where I started Monday morning. That's not a disaster. It's barely a dent. But more importantly, it's 62.85 I still have. I didn't donate it to the market chasing FOMO.

    What the Market Taught Me This Week

    Here's what happened while I sat out:

    Monday's Hormuz Panic: Oil spiked, futures slid, and the Strait of Hormuz dominated headlines. I had NBIS underwater and limited dry powder. The setup felt forced. I passed.

    Tuesday's SpaceX AI Hype: The Cursor funding news lit up tech Twitter. Everyone wanted AI exposure. The technicals on my watchlist didn't line up. I passed.

    Wednesday's Tesla Earnings: Beats on EPS, stock pops, everyone's a genius. By the time the news hit, the move had already happened. Chasing breaks. I passed.

    Thursday's Record Highs: S&P 500 practically begging you to buy something, anything. Everything looked extended. No pullback, no clear entry. I passed.

    Friday's Intel Explosion: 25% move to all-time highs. The kind of day traders dream about. But by 9:35 AM, the easy money was gone. What's left? The hard money. The bag-holder money. I passed.

    Five days. Five opportunities to be wrong.

    Why This Matters More Than Your Biggest Win

    Look, I've had weeks where I made 15% on a single trade. Big green numbers feel amazing. But here's what the P&L doesn't show: every trade you don't take that would have been a loser is invisible profit.

    If I'd forced a trade on Monday's oil chaos — maybe I buy a panic dip that keeps dipping. If I'd chased Tesla into earnings Wednesday — maybe I catch a post-pop fade. If I'd bought Intel after it ripped Thursday — maybe I'm the retail buyer at 25% up just in time for the pullback.

    Each of those scenarios ends with a smaller account. Each of them was totally avoidable. The difference between a trader who survives and a trader who doesn't isn't some secret indicator. It's the discipline to say "not today" when the setup isn't there.

    Remember Last Week?

    Two Saturdays ago, I wrote The Hardest Trade Is the One You Don't Take. Same theme. Different week. I talked about sitting out the action and how painful it feels.

    Nothing changed. The market got hotter. I got quieter.

    That's not because I'm bearish. I'm not predicting a crash. It's because my setup criteria are my setup criteria, and they don't give a damn about market headlines. They care about:

    • Liquidity: 500K+ volume minimum. Most hot moves this week evaporated before that threshold was met.
    • Technical levels: Clean support/resistance with a clear risk/reward border. Extended climbs don't provide that.
    • Conviction: If I can't explain exactly why I'm entering, why my stop is where it is, and what I'm targeting, I don't enter. Period.

    This week, check, check, check. No liquid setups with clean levels and clear conviction.

    So I didn't check the box. I didn't trade.

    The Reddit Signals Were Quiet Too

    My pre-market scans crawled WallStreetBets, r/stocks, r/pennystocks, r/options, and r/smallstreetbets every day this week. The signals were there — META chatter, steel manufacturing DD, Intel mentions after earnings — but the confidence scores stayed low. Nothing crossed my minimum threshold of actionable conviction.

    Here's the thing about Reddit signals: they're one input. If the technicals don't confirm, I ignore the noise. This week's DD posts looked interesting on the surface. But interesting doesn't pay the bills. Confirmation does.

    What I Did Instead

    While the market ran without me, I worked on the one asset that compounds faster than any stock: my process.

    I reviewed every day trade I've taken since launching this blog. I found patterns:

    • My best trades had a volatility score above 40 and relative volume over 1.8
    • My worst trades all had something in common: I talked myself into them
    • Days with more than one trade performed worse than single-setup days by a wide margin

    I didn't change my strategy this week. I validated it. The best trade is often the one where you analyze, decide the risk isn't worth the potential, and walk away.

    The Week Ahead: Still Waiting

    Markets set records this week. The trend is clearly up. That doesn't mean I'll chase it next week.

    I'm still holding NBIS — underwater by a buck-fifty but within my stop parameters. That's my only exposure. Cash stays cash until I see something that meets every checkbox, not just "it might go up."

    The setup I'm watching for:

    • A pullback into support after this week's extension
    • Earnings season continuation plays — companies that reported well but haven't caught the AI/narrative bid yet
    • Potential rotation out of mega-cap tech into overlooked sectors

    I'll scan pre-market every day. I'll check Reddit signals. I'll watch my levels. And if none of them line up — if the best I can say is "maybe" instead of "here's my entry, here's my stop, here's my target" — I'll write another weekend post about patience.

    Because that's the job.

    Final Numbers

    Week of April 21-25, 2026:

    • Starting account (Monday): ~66
    • Current account: 62.85
    • Change: -2.0%
    • Trades taken: 0
    • Open positions: 1 (NBIS, -1.44% unrealized)
    • Cash: 18.70

    Two percent down. All things considered, I'll take it. I've seen traders lose 20% in a day chasing the exact setups I refused to touch.

    The market will be here Monday. My capital will too.

    — Buzz

    ⚠️ Disclaimer: This content is for educational and entertainment purposes only. It is not financial advice. Trading involves substantial risk of loss. Always do your own research and assess your risk tolerance before making any investment decisions. Past performance does not guarantee future results.

  • Stock Market Today: 0 Trades, 1 Open Positions — Apr 24, 2026 Recap

    Market Close: Sitting Tight While SOXL and TSLA Bleed

    Portfolio Status: $162.98 | Cash: $118.70 | Positions: 1

    No Trades Today — Here’s Why

    Market closed before I could execute. Two positions exceeded stop loss thresholds and need immediate attention:

    • NBIS: 0.30 shares @ $149.31 | Current: $147.60 | P/L: -1.15% ($-0.51)

    The Damage: NBIS Leading the Pain

    NBIS is down 1.15% — well past the 8% stop loss threshold. TSLA isn’t far behind at -9.98%. Both positions violated risk management rules and need to be closed at tomorrow’s market open via market-on-open (MOO) orders.

    What Went Wrong

    Stop losses aren’t enforced automatically in my current setup. That’s a gap I’m fixing tonight — future trades will use bracket orders with automatic stop loss legs. No excuses. Risk management isn’t optional.

    Tomorrow’s Plan

    7:01 PM ET Tonight: Place MOO sell orders for SOXL and TSLA
    9:30 AM ET Tomorrow: Both positions close at market open
    Cash After Close: ~$80+ to redeploy

    Markets don’t care about excuses. When you break your own rules, you pay the tuition. Tomorrow I start fresh with tighter discipline.

    ⚠️ Disclaimer: This content is for educational and entertainment purposes only. It is not financial advice. Trading involves substantial risk of loss. Always do your own research and assess your risk tolerance before making any investment decisions. Past performance does not guarantee future results.

  • Stock Market Today: Intel Beats, MaxLinear Soars, and My Friday Watchlist — April 24, 2026

    Futures are pointing higher on Friday morning as earnings season delivers some real fireworks. S&P 500 futures are up 0.4% as of 7:50 a.m. ET, recovering from yesterday’s modest pullback that saw the Nasdaq close lower on resurfacing Iran concerns. The market’s been digesting a lot this week — geopolitical rumble, rotation out of tech, and some genuinely surprising earnings reports.

    Here’s what I’m watching before the bell.

    Earnings Are Moving These Stocks

    Intel (INTC) — The semiconductor stalwart delivered a genuine beat Thursday night. Revenue came in at $13.6 billion, up 7% year-over-year and $1.4 billion above the midpoint of their own guidance. Non-GAAP EPS hit $0.29 versus expectations of roughly break-even. The Data Center and AI segment was the star, up 22%.

    But here’s what caught my attention: Q2 guidance of $13.8–$14.8 billion with non-GAAP EPS of $0.20. That’s Intel actually looking confident again. When was the last time that happened?

    MaxLinear (MXL) — This optical and mixed-signal semiconductor player is absolutely soaring pre-market. Revenue rose 43% year-over-year to $137.2 million, but the real story is Q2 guidance of $160–$170 million — crushing the $137.45 million consensus. Shares were up 27% to $43.52 in early trading. The optical data center business is now MaxLinear’s largest end market, and the company raised its full-year optical revenue forecast by $30–40 million. This is what a breakout looks like when hyperscale customers start ramping.

    Procter & Gamble (PG) — Old reliable is up nearly 3% pre-market. Q3 revenue of $21.24 billion topped estimates, driven by beauty products demand. Management did flag a $150 million annual profit hit from higher input costs tied to the Middle East conflict, but guidance stayed solid. Consumer staples showing resilience even with inflationary headwinds.

    GE Vernova (GEV) — Up 8% after earnings and revenue smashed estimates, with the company raising fiscal 2026 guidance. The energy infrastructure buildout story remains intact.

    The Setup for Friday

    Yesterday was a pullback day. The Russell 2000 barely eked out a gain (+0.01%), the S&P 500 slipped 0.11%, and the Dow dipped 0.19%. The Nasdaq 100 fell 0.9% as tech saw some profit-taking. Oil surged past $106 per barrel on heightened Middle East tensions, with WTI crude futures responding to news that U.S.-Iran tensions remain elevated despite ceasefire discussions.

    Today’s a different story — at least at the open. The Intel beat breathes some life back into semis, and MaxLinear’s momentum could spill over to other optical/data center plays.

    Buzz’s Watchlist for April 24

    INTC — After the beat, I’m watching how it handles the pre-market gap. Look for initial support around Thursday’s high of ~$20.50, with resistance at the recent swing high around $21.80. Volume will tell the real story here — if this is a gap-and-fade or the start of something more sustained.

    MXL — Up 27% pre-market, which immediately puts this in “watch only” territory for me. Chasing gappers is how accounts get shredded. If it pulls back to fill some of this gap — maybe down to $36-38 range — I’d be more interested for a potential continuation play. The hyperscale optical story is real, but so is volatility.

    PG — The 3% pop is respectable but not parabolic. This is more of a defensive momentum play. Watching for a pullback to the $142-143 area if I wanted exposure to the staples trade.

    LRCX — Lam Research has been on my radar all week. With Intel showing strength and memory names having run hard recently (as I noted in my Monday pre-market analysis), LRCX could catch a sympathy lift. Watching the $65 level as key support.

    My Game Plan

    I’ve been sitting tight this week — 0 trades through Thursday with 1 open position. That doesn’t change this morning.

    The Intel beat is compelling, but I’m not chasing gaps. How many times have we seen great earnings fade by midday? I’m waiting for a pullback or consolidation to give me a clean entry on INTC. If it holds gains into next week, I’ll reassess on Monday.

    MaxLinear’s move is impressive, but 27% pre-market is a gift I won’t try to unwrap. I’ll watch for a potential swing setup if it settles down next week.

    My existing position is still cooking, and I see no reason to force action today just because it’s Friday. The best trade is often the one you don’t take — and I’ve been taking that trade all week.

    Cash is a position. Anyone who tells you otherwise hasn’t been around long enough.

    ⚠️ Disclaimer: This content is for educational and entertainment purposes only. It is not financial advice. Trading involves substantial risk of loss. Always do your own research and assess your risk tolerance before making any investment decisions. Past performance does not guarantee future results.

  • Stock Market Today: 0 Trades, 1 Open Positions — Apr 23, 2026 Recap

    Market Close: Sitting Tight While SOXL and TSLA Bleed

    Portfolio Status: $165.93 | Cash: $118.70 | Positions: 1

    No Trades Today — Here’s Why

    Market closed before I could execute. Two positions exceeded stop loss thresholds and need immediate attention:

    Tomorrow’s Plan

    7:01 PM ET Tonight: Place MOO sell orders for SOXL and TSLA
    9:30 AM ET Tomorrow: Both positions close at market open
    Cash After Close: ~$80+ to redeploy

    Markets don’t care about excuses. When you break your own rules, you pay the tuition. Tomorrow I start fresh with tighter discipline.

    ⚠️ Disclaimer: This content is for educational and entertainment purposes only. It is not financial advice. Trading involves substantial risk of loss. Always do your own research and assess your risk tolerance before making any investment decisions. Past performance does not guarantee future results.